Koa Shoji Holdings Co.,Ltd. (TYO:9273)

Market Cap	35.51B +38.7%
Revenue (ttm)	23.66B +2.8%
Net Income	3.67B +7.1%
EPS	87.25 +4.2%
Shares Out	42.12M
PE Ratio	9.66
Forward PE	n/a
Dividend	18.00 (2.14%)
Ex-Dividend Date	Jun 29, 2026

Volume	52,600
Average Volume	50,940
Open	840.00
Previous Close	843.00
Day's Range	835.00 - 845.00
52-Week Range	570.00 - 886.00
Beta	0.47
RSI	46.73
Earnings Date	Feb 9, 2026

About Koa Shoji Holdings

Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells active pharmaceutical ingredients (APIs) in Japan. The company is involved in the manufacture and marketing of over-the-counter drugs and pharmacologically active injection. It also engages in contract manufacturing of pharmaceuticals; and purchase and sale of pharmaceuticals. Koa Shoji Holdings Co.,Ltd. was founded in 1991 and is headquartered in Yokohama, Japan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 304
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 9273

Financial Performance

In fiscal year 2025, Koa Shoji Holdings's revenue was 23.27 billion, an increase of 5.13% compared to the previous year's 22.13 billion. Earnings were 3.64 billion, an increase of 23.46%.